Immune Trombocytopenia (ITP)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy, as determined by screening assessments and judgement of researchers >18 years old Informed consent
Exclusion criteria
Exclusion criteria: Pregnancy or planning to become pregnant during the study period Liver disease (Child Pugh >7) Hematological/ platelet/ bone marrow disease in history or in co-existence Autoimmune disease in history or in co-existence Transplantation in history (Partial) splenectomy in history Any other clinically relevant history as determined by screening assessments and the judgement of the researchers , •(Suspected) allergy to one of the isotopes or contents used for platelet scintigraphy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The platelet sequestration pattern (% splenic, % hepatic, %mixed) in healthy subjects. | — |
Secondary
| Measure | Time frame |
|---|---|
| Platelet counts before and after scan (x10^9/ L) Platelet half life (in hours) Mean platelet life span (in hours) Mean platelet turnover (in hours) Labelling percentage (in %) Percentage of platelets remaining in the circulation after 48 hours (in %) Differences between sequestration patterns in healthy adults an ITP patients (in S:L ratio) Differences between sequestration patterns in heathy individuals over time (in S:L ratio) | — |
Countries
Netherlands